Recombinant factor VIIa for intractable life-threatening bleeding in patients with circulatory assist devices.
Schneider
Antoine G
AG
Perez
Marie-Hélène
MH
Tozzi
Piergiorgio
P
Voirol
Pierre
P
Schoettker
Patrick
P
Angelillo-Scherrer
Anne
A
Cotting
Jacques
J
Von Segesser
Ludwig
L
Eggimann
Philippe
P
D000293:Adolescent; D000328:Adult; D001243:Assisted Circulation / Q000009:adverse effects*; D002648:Child; D003029:Coagulants / Q000008:administration & dosage*; D003422:Critical Care / Q000379:methods*; D015942:Factor VIIa / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007223:Infant; D007431:Intraoperative Complications / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D019106:Postoperative Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D011994:Recombinant Proteins / Q000008:administration & dosage; D016896:Treatment Outcome
D003029:Coagulants; D011994:Recombinant Proteins; C103587:recombinant FVIIa; D015942:Factor VIIa